Small-molecule kinase inhibitors for the treatment of nononcologic diseases

Z Xie, X Yang, Y Duan, J Han… - Journal of medicinal …, 2021 - ACS Publications
Great successes have been achieved in developing small-molecule kinase inhibitors as
anticancer therapeutic agents. However, kinase deregulation plays essential roles not only …
被引用次数：58 相关文章
[PDF] researchgate.net

[PDF][PDF] Small-Molecule Kinase Inhibitors for the Treatment of Nononcologic Diseases

J. Med. Chem, 2021 - researchgate.net
Great successes have been achieved in developing small-molecule kinase inhibitors as
anticancer therapeutic agents. However, kinase deregulation plays essential roles not only …

Small-Molecule Kinase Inhibitors for the Treatment of Nononcologic Diseases

Z Xie, X Yang, Y Duan, J Han… - Journal of medicinal …, 2021 - pubmed.ncbi.nlm.nih.gov
Great successes have been achieved in developing small-molecule kinase inhibitors as
anticancer therapeutic agents. However, kinase deregulation plays essential roles not only …

[引用][C] Small-Molecule Kinase Inhibitors for the Treatment of Nononcologic Diseases

Z Xie, X Yang, Y Duan, J Han, C Liao - Journal of Medicinal Chemistry, 2021 - cir.nii.ac.jp
Small-Molecule Kinase Inhibitors for the Treatment of Nononcologic Diseases | CiNii
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ …

Small-Molecule Kinase Inhibitors for the Treatment of Nononcologic Diseases.

Z Xie, X Yang, Y Duan, J Han, C Liao - Journal of Medicinal …, 2021 - europepmc.org
Great successes have been achieved in developing small-molecule kinase inhibitors as
anticancer therapeutic agents. However, kinase deregulation plays essential roles not only …